Efficacy of Natalizumab extended dosing in multiple sclerosis: a retrospective multicenter analysis

被引：0
|
作者：
Ryerson, L. Zhovtis [1 ]
Herbert, J. [1 ]
Tornatore, C. [2 ]
Foley, J. [3 ]
Weinstock-Guttman, B. [4 ]
Kister, I. [1 ]
Pandey, K. [5 ]
Hojnacki, D. [4 ]
Remington, G. [6 ]
Frohman, T. [6 ]
Major, E. [7 ]
Douek, D. [8 ]
Qureshi, S. [6 ]
Beh, J. [6 ]
Okuda, D. [6 ]
Utomo, P. [1 ]
Hoyt, T. [3 ]
Chamot, E. [9 ]
Bucello, M. [4 ]
Ahsan, I. [4 ]
Kolb, C. [4 ]
Frohman, E. [6 ]
机构：
[1] NYU, Langone Med Ctr, New York, NY USA
[2] Georgetown Univ Hosp, Neurol, Washington, DC 20007 USA
[3] Rocky Mt MS Clin, Salt Lake City, UT USA
[4] SUNY Buffalo, Neurol, Buffalo, NY 14260 USA
[5] Barnabas Hlth MS Ctr, Neurol, Livingston, NJ USA
[6] Univ Texas SW Med Ctr Dallas, Neurol, Dallas, TX 75390 USA
[7] NINDS, Bethesda, MD 20892 USA
[8] Natl Inst Allergy & Immunol, Bethesda, MD USA
[9] Univ Alabama Birmingham, Birmingham, AL USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P287
引用
收藏
页码：194 / 195
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of natalizumab in children with multiple sclerosis
    Ghezzi, A.
    Pozzilli, C.
    Grimaldi, L. M. E.
    Morra, V. Brescia
    Bortolon, F.
    Capra, R.
    Filippi, M.
    Moiola, L.
    Rocca, M. A.
    Rottoli, M.
    Sarchielli, P.
    Zaffaroni, M.
    Comi, G.
    NEUROLOGY, 2010, 75 (10) : 912 - 917
  • [32] Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program
    van Pesch, Vincent
    Bartholome, Emmanuel
    Bissay, Veronique
    Bouquiaux, Olivier
    Bureau, Michel
    Caekebeke, Jo
    Debruyne, Jan
    Declercq, Inge
    Decoo, Dany
    Denayer, Pierre
    De Smet, Eric
    D'hooghe, Marie
    Dubois, Benedicte
    Dupuis, Michel
    El Sankari, Souraya
    Geens, Karine
    Guillaume, Daniel
    van Landegem, William
    Lysandropoulos, Andreas
    de Noordhout, Alain Maertens
    Medaer, Robert
    Melin, Annick
    Peeters, Katelijne
    Remy Phan Ba
    Retif, Cecile
    Seeldrayers, Pierrette
    Symons, Anoek
    Urbain, Etienne
    Vanderdonckt, Patrick
    Van Ingelghem, Erwin
    Vanopdenbosch, Ludo
    Vanroose, Erwin
    Van Wijmeersch, Bart
    Willekens, Barbara
    Willems, Christiana
    Sindic, Christian
    ACTA NEUROLOGICA BELGICA, 2014, 114 (03) : 167 - 178
  • [33] Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program
    Vincent van Pesch
    Emmanuel Bartholomé
    Véronique Bissay
    Olivier Bouquiaux
    Michel Bureau
    Jo Caekebeke
    Jan Debruyne
    Inge Declercq
    Dany Decoo
    Pierre Denayer
    Eric De Smet
    Marie D’hooghe
    Bénédicte Dubois
    Michel Dupuis
    Souraya El Sankari
    Karine Geens
    Daniel Guillaume
    William van Landegem
    Andreas Lysandropoulos
    Alain Maertens de Noordhout
    Robert Medaer
    Annick Melin
    Katelijne Peeters
    Rémy Phan Ba
    Cécile Retif
    Pierrette Seeldrayers
    Anoek Symons
    Etienne Urbain
    Patrick Vanderdonckt
    Erwin Van Ingelghem
    Ludo Vanopdenbosch
    Erwin Vanroose
    Bart Van Wijmeersch
    Barbara Willekens
    Christiana Willems
    Christian Sindic
    Acta Neurologica Belgica, 2014, 114 : 167 - 178
  • [34] A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis
    Nikfar, Shekoufeh
    Rahimi, Roja
    Rezaie, Ali
    Abdollahi, Mohammad
    ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (02) : 236 - 244
  • [35] EFFICACY AND TOLERABILITY OF NATALIZUMAB IN RELAPSING MULTIPLE SCLEROSIS; A META-ANALYSIS
    Nikfar, S.
    Rahimi, R.
    Rezaie, A.
    Abdollahi, M.
    VALUE IN HEALTH, 2009, 12 (07) : A365 - A366
  • [36] Long-Term Efficacy and Tolerability of Natalizumab Treatment in Multiple Sclerosis Patients: A Multicenter Experience
    Totaro, Rocco
    Bellantonio, Paolo
    Costantino, Gianfranco
    Maccarone, Barbara
    Fantozzi, Roberta
    Fuiani, Aurora
    Mundi, Ciro
    Ruggieri, Stefano
    Carolei, Antonio
    NEUROLOGY, 2011, 76 (09) : A242 - A242
  • [37] Extended interval dosing with ocrelizumab in multiple sclerosis
    Novak, Frederik
    Bajwa, Hamza Mahmood
    Ostergaard, Kamilla
    Berg, Jonas Munksgaard
    Madsen, Jonna Skov
    Olsen, Dorte Aalund
    Urbonaviciute, Inga
    Illes, Zsolt
    Stilund, Morten Leif
    Christensen, Jeppe Romme
    Bramow, Stephan
    Sellebjerg, Finn
    Sejbaek, Tobias
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (07) : 847 - 856
  • [38] Extended dosing of monoclonal antibodies in multiple sclerosis
    Kempen, Zoe L. E. van
    Toorop, Alyssa A.
    Sellebjerg, Finn
    Giovannoni, Gavin
    Killestein, Joep
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (13) : 2001 - 2009
  • [39] Acta neurologica belgica regarding the manuscript entitled 'Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients: a systematic review and meta-analysis'
    Boggild, Mike
    Mohammadpour, Zinat
    van Eijk, Liza
    Williams, Lachlan
    ACTA NEUROLOGICA BELGICA, 2025,
  • [40] Pharmacokinetic Model-Informed Precision Dosing of Natalizumab in Multiple Sclerosis
    van den Berg, Stefan P. H.
    Toorop, Alyssa A.
    Hooijberg, Femke
    Wolbink, Gertjan
    Voelkner, Nivea M. F.
    Gelissen, Liza M. Y.
    Killestein, Joep
    van Kempen, Zoe L. E.
    Dorlo, Thomas P. C.
    Rispens, Theo
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025,
12345